ProMIS Neurosciences, Inc.
General ticker "PMN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $46.3M (TTM average)
ProMIS Neurosciences, Inc. does not follow the US Stock Market performance with the rate: -11.5%.
Estimated limits based on current volatility of 5.7%: low 13.05$, high 14.64$
Factors to consider:
- Total employees count: 11 (+37.5%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: No approved products, Regulatory and compliance, Financing unavailable, Manufacturing scale up, Market acceptance
- Current price 12.4% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [4.56$, 13.52$]
- 2026-12-31 to 2027-12-31 estimated range: [3.12$, 9.72$]
Financial Metrics affecting the PMN estimates:
- Negative: with PPE of -0.7 at the end of fiscal year the price was high
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 0 > -0.60
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Negative: Shareholder equity ratio, % of -13.71 <= 19.19
- Negative: -0.75 < Inventory ratio change, % of 0
- Negative: negative Industry operating cash flow (median)
Short-term PMN quotes
Long-term PMN plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.26MM | $16.83MM | $40.17MM |
| Operating Income | $-14.26MM | $-16.83MM | $-40.17MM |
| Non-Operating Income | $1.05MM | $19.61MM | $0.45MM |
| Interest Expense | $0.20MM | $0.08MM | $0.00MM |
| R&D Expense | $7.88MM | $10.64MM | $33.38MM |
| Income(Loss) | $-13.21MM | $2.78MM | $-39.72MM |
| Net Income(Loss)* | $-13.21MM | $2.78MM | $-39.72MM |
| Stockholders Equity | $3.75MM | $16.49MM | $-1.26MM |
| Assets | $13.62MM | $18.91MM | $9.18MM |
| Operating Cash Flow | $-10.84MM | $-27.18MM | $-28.12MM |
| Investing Cash Flow | $-0.00MM | $-0.00MM | $-0.00MM |
| Financing Cash Flow | $17.75MM | $27.88MM | $20.94MM |
| Earnings Per Share** | $-26.87 | $2.68 | $-0.02 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.